BioLineRx Ltd. (BLRX)

NASDAQ: BLRX · Real-Time Price · USD

3.44

-0.03 (-0.86%)

At close: May 01, 2025, 3:58 PM

3.50

1.89%

After-hours: May 01, 2025, 07:01 PM EDT

BioLineRx Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	28.94M	4.8M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	9.26M	3.69M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	19.68M	1.11M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-20.41M	-49.69M	-29.16M	-24.78M	-22.93M	-28.11M	-25.61M	-25.24M	-16.51M
Interest Income	1.82M	2.01M	694K	559K	236K	777K	719K	1.17M	480K
Pretax Income	-9.22M	-60.61M	-24.95M	-27.05M	-30.02M	-25.45M	-22.96M	-24.35M	-15.84M
Net Income	-9.22M	-60.61M	-20.75M	-28.14M	-30.93M	-26.81M	-22.96M	-24.35M	-15.84M
Selling & General & Admin	28.54M	31.23M	11.53M	5.27M	4.68M	4.59M	5.77M	5.73M	5.31M
Research & Development	9.15M	12.52M	17.63M	19.47M	18.17M	23.44M	19.81M	19.51M	11.18M
Other Expenses	2.4M	7.05M	5.67M	42K	70K	78K	154K	-260K	7K
Operating Expenses	40.09M	50.8M	29.16M	24.78M	22.93M	28.11M	25.61M	25.24M	16.51M
Interest Expense	9.12M	2.14M	2.16M	984K	1.47M	1.83M	21K	21K	14K
Selling & Marketing Expenses	10.08M	14.59M	6.46M	1M	840K	857K	1.36M	1.69M	1.35M
Cost & Expenses	49.35M	54.49M	29.16M	24.78M	22.93M	28.11M	25.61M	25.24M	16.51M
Income Tax Expense	n/a	n/a	-4.21M	1.09M	911K	1.36M	2.66M	-239K	-665K
Shares Outstanding (Basic)	2M	64.22M	51.6M	44.2M	16.86M	9.76M	7.24M	6M	3.74M
Shares Outstanding (Diluted)	2M	64.22M	51.6M	44.2M	16.86M	9.76M	7.24M	6M	3.74M
EPS (Basic)	-6	-0.94	-0.4	-0.64	-1.8	-2.7	-3.15	-4.05	-4.2
EPS (Diluted)	-6	-0.94	-0.4	-0.64	-1.8	-2.7	-3.15	-4.05	-4.2
EBITDA	3.99M	-57.09M	-28.5M	-24.07M	-22.34M	-26.89M	-26.85M	-23.85M	-16.23M
EBIT	-147K	-58.47M	-29.16M	-24.78M	-22.93M	-28.11M	-25.61M	-25.24M	-16.51M
Depreciation & Amortization	4.07M	1.38M	654K	703K	934K	940K	451K	438K	454K